Further, the frequency of genomic alterations in patients with stage III to IVA cervical cancer in TCGA dataset was as follows: PIK3CA (30%), FBXW7 (15%), PTEN (15%), and TP53 (11%) (Figure S2). Here, TP53 is linked to cervical cancer.